Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
398.99B | 384.82B | 344.61B | 288.21B | 267.75B | 264.81B | Gross Profit |
143.84B | 123.17B | 119.70B | 104.28B | 94.68B | 92.72B | EBIT |
46.31B | 42.06B | 29.06B | 35.73B | 31.53B | 27.48B | EBITDA |
81.26B | 75.15B | 60.57B | 53.78B | 50.14B | 45.69B | Net Income Common Stockholders |
31.52B | 29.19B | 20.13B | 18.47B | 19.09B | 18.29B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
44.86B | 54.01B | 53.83B | 48.80B | 65.05B | 52.78B | Total Assets |
251.62B | 557.41B | 501.54B | 469.98B | 424.93B | 387.75B | Total Debt |
8.58B | 101.19B | 100.07B | 58.68B | 51.35B | 54.61B | Net Debt |
-7.79B | 47.18B | 49.60B | 12.95B | -10.88B | 4.40B | Total Liabilities |
57.68B | 224.00B | 205.78B | 192.12B | 167.09B | 143.64B | Stockholders Equity |
192.59B | 331.26B | 293.98B | 271.91B | 253.09B | 242.44B |
Cash Flow | Free Cash Flow | ||||
37.51B | 18.82B | -6.35B | -28.40B | 24.04B | 4.67B | Operating Cash Flow |
82.92B | 50.87B | 48.63B | 28.74B | 40.00B | 37.38B | Investing Cash Flow |
-46.24B | -35.80B | -46.27B | -39.93B | -10.77B | -43.68B | Financing Cash Flow |
-26.86B | -15.34B | 1.10B | -7.93B | -18.85B | 21.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$4.08B | 30.92 | 6.03% | 1.67% | ― | ― | ||
66 Neutral | $4.50B | 12.29 | 5.40% | 248.66% | 4.13% | -12.33% | |
$531.08M | 14.05 | 8.79% | 2.29% | ― | ― | ||
$1.08B | 14.70 | 9.36% | 3.48% | ― | ― | ||
76 Outperform | ¥86.98B | 13.25 | 3.80% | 12.10% | 148.39% | ||
75 Outperform | ¥345.54B | 14.33 | 2.12% | 8.59% | 39.41% | ||
74 Outperform | ¥159.26B | 7.20 | 2.65% | 9.84% | 16.55% |